Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study
Saved in:
| Published in: | PeerJ |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1864030190496120834 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | PeerJ |
| description | |
| discipline_display | Multidisciplinary |
| discipline_facet | Multidisciplinary |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:7664 |
| institution | FRELIP |
| journal_source_facet | PeerJ |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study Multidisciplinary General Multidisciplinary |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Multidisciplinary General Multidisciplinary Multidisciplinary General Multidisciplinary |
| subject_facet | Multidisciplinary General Multidisciplinary |
| title | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study |
| title_auth | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study |
| title_full | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study |
| title_fullStr | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study |
| title_full_unstemmed | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study |
| title_short | Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study |
| title_sort | impact of proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (ldl-c) reduction: a real-world observational study |
| topic | Multidisciplinary General Multidisciplinary |
| url | https://peerj.com/articles/20668 |